Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million
In Brief: NCAB Still Without New Appinees As Carter, Califano Delay Drags On; Keele to U. Kansas
New Staff Proposals For Comprehensive Center Recognition Considered By NCAB
DCT Announces Neutron Therapy RFP Available
Rall Says NTP to Put 50-75 Chemicals On Long Term Tests
NCAB Subcommittee Worries About Board’s Makeup
Court Forces CPSC To Reopen Carcinogen Policy
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds
- Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions
- A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m. - OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill
- A new diagnostic lens—and a lasting scientific legacy









